Table 1 The clinicopathological characteristics of included patients and their correlations with the expression of PBK/TOPK

 ≤ 50 y

94 (46.5)

52 (55.3)

42 (44.7)

−0.049

0.487

 > 50 y

108 (53.5)

65 (60.2)

43 (39.8)

 Premenopausal

115 (56.9)

63 (54.8)

52 (45.2)

−0.073

0.301

 Postmenopausal

87(43.1)

54 (62.1)

33 (37.9)

 ≤ 2 cm

95 (47.0)

61 (64.2)

34 (35.8)

 > 2 cm ≤ 5 cm

96 (47.6)

51 (53.1)

45 (46.9)

0.124

0.078

 > 5 cm

11 (5.4)

5 (45.5)

6 (54.5)

 G1

20 (9.9)

13 (65.0)

7 (35.0)

 G2

147 (72.8)

93 (63.3)

54 (36.7)

0.171

0.015*

 G3

35 (17.3)

11 (31.4)

24 (68.6)

 I

66 (32.7)

45 (68.2)

21 (31.8)

 II

95 (47.0)

54 (56.8)

41 (43.2)

0.175

0.013*

 III

41 (20.3)

18 (43.9)

23 (56.1)

 No

172 (85.1)

103 (59.9)

69 (40.1)

0.095

0.178

 Yes

30 (14.9)

14 (46.7)

16 (53.3)

 No

113 (55.9)

76 (67.2)

37 (32.8)

0.213

0.002*

 Yes

89 (44.1)

41 (46.1)

48 (53.9)

 1–3

56 (27.7)

29 (51.8)

27 (48.2)

 4–9

20 (9.9)

10 (50.0)

10 (50.0)

0.241

0.001*

 ≥ 10

13 (6.5)

2 (15.4)

11 (84.6)

 Negative

53 (26.2)

22 (41.5)

31 (58.5)

−0.198

0.005*

 Positive

149 (73.8)

95 (63.8)

54 (36.2)

 Negative

110 (54.5)

56 (50.9)

54 (49.1)

−0.155

0.027*

 Positive

92 (45.5)

61 (66.3)

31 (33.7)

 Negative

137 (67.8)

85 (62.0)

52 (38.0)

0.153

0.037*

 Positive

49 (24.2)

22 (44.9)

27 (55.1)

 Low expression

65 (32.2)

52 (80.0)

13 (20.0)

0.312

< 0.001*

 High expression

137 (67.8)

64 (46.7)

73 (53.3)

 Luminal A

33 (16.3)

30 (90.9)

3 (9.1)

22.031^

< 0.001^

 Luminal B

74 (36.6)

43 (58.1)

31 (41.9)

 HER-2(+)

49 (24.2)

22 (44.9)

27 (55.1)

 TNBC

30 (14.9)

12 (40.0)

18 (60.0)